ARNA

Investment Analysis Clubs Saul’s Investing Discussions
1

https://finance.yahoo.com/news/arena-pharmaceuticals-united-…

  • Arena will receive $800M upfront, and is eligible to receive low double-digit tiered royalties, plus up to $400M in milestone payments

  • United Therapeutics will receive exclusive, worldwide rights to ralinepag - a potential best-in-class agent for the treatment of pulmonary arterial hypertension

Up 17% pre market.

Cheers,

WM33

5 Likes
2

ralinepag

That’s not even the drug Bulwnkl was excited about (Etrasimod). But the bump is nice!

Bear

1 Like
3

Yup. Beats a poke in the eye. Even though we have a 3-yr wait for Etrasimod, their are many ways the needle can be moved between now and Estasimod’s approval.

Best,

bulwnkl

Long ARNA :o)

Long NVDA :o(

2 Likes